Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | NYSE | Healthcare | Healthcare Providers & Services | $57.90B | 11.6x | -0.28 | $46.01 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.9% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | NYSE | Basic Materials | Chemicals | $23.69B | 11.2x | -1.93 | $73.03 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.2% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | NYSE | Healthcare | Pharmaceuticals | $152.22B | 35.9x | -0.59 | $26.86 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.4% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | NYSE | Real Estate | Residential & Commercial REITs | $17.02B | 59.3x | 3.4 | $97.39 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.2% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | NYSE | Real Estate | Residential & Commercial REITs | $14.50B | 42x | 3.9 | $20.32 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | NYSE | Real Estate | Residential & Commercial REITs | $30.39B | 10.6x | 0.82 | $28.83 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ |